Objective: To determine the extent and nature of selective non-reporting of harm outcomes in clinical studies that were eligible for inclusion in a cohort of systematic reviews. Design: Cohort study of systematic reviews from two databases. Setting: Outcome reporting bias in trials for harm outcomes (ORBIT II) in systematic reviews from the Cochrane Library and a separate cohort of systematic reviews of adverse events. Participants: 92 systematic reviews of randomised controlled trials and non-randomised studies published in the Cochrane Library between issue 9, 2012 and issue 2, 2013 (Cochrane cohort) and 230 systematic reviews published between 1 January 2007 and 31 December 2011 in other publications, synthesising data on harm outcomes (...
Objective: To assess how information about adverse events is included in systematic reviews. Study D...
Background: Selective reporting bias (SRB), the incomplete publication of outcomes ...
Study publication bias and outcome reporting bias have been recognised as two threats to the validit...
Objective To determine the extent and nature of selective non-reporting of harm outcomes in clinical...
To examine the prevalence of consequence stating bias, the selection for publication of a subset of ...
OBJECTIVE: To examine the prevalence of outcome reporting bias-the selection for publication of a su...
Systematic reviews of clinical trials aim to include all relevant studies conducted on a particular ...
Background Discrepancies in outcome reporting (DOR) between protocol and published studies include i...
BACKGROUND: The increased use of meta-analysis in systematic reviews of healthcare interventions has...
Background The increased use of meta-analysis in systematic reviews of healthcare interventions has ...
Background: Selective reporting is included as a core domain of Cochrane's tool for assessing risk o...
Background Most publications about selective reporting in clinical trials have focussed on outcomes....
Objectives: To describe how systematic reviewers are reporting missing data for dichotomous outcomes...
OBJECTIVE: We examined how assessments of risk of bias of primary studies are carried out and incorp...
Background Adding, omitting or changing outcomes after a systematic review protocol is published can...
Objective: To assess how information about adverse events is included in systematic reviews. Study D...
Background: Selective reporting bias (SRB), the incomplete publication of outcomes ...
Study publication bias and outcome reporting bias have been recognised as two threats to the validit...
Objective To determine the extent and nature of selective non-reporting of harm outcomes in clinical...
To examine the prevalence of consequence stating bias, the selection for publication of a subset of ...
OBJECTIVE: To examine the prevalence of outcome reporting bias-the selection for publication of a su...
Systematic reviews of clinical trials aim to include all relevant studies conducted on a particular ...
Background Discrepancies in outcome reporting (DOR) between protocol and published studies include i...
BACKGROUND: The increased use of meta-analysis in systematic reviews of healthcare interventions has...
Background The increased use of meta-analysis in systematic reviews of healthcare interventions has ...
Background: Selective reporting is included as a core domain of Cochrane's tool for assessing risk o...
Background Most publications about selective reporting in clinical trials have focussed on outcomes....
Objectives: To describe how systematic reviewers are reporting missing data for dichotomous outcomes...
OBJECTIVE: We examined how assessments of risk of bias of primary studies are carried out and incorp...
Background Adding, omitting or changing outcomes after a systematic review protocol is published can...
Objective: To assess how information about adverse events is included in systematic reviews. Study D...
Background: Selective reporting bias (SRB), the incomplete publication of outcomes ...
Study publication bias and outcome reporting bias have been recognised as two threats to the validit...